PNP3 COST-BENEFIT ANALYSIS OF ALMOTRIPTAN FROM A SOCIETAL PERSPECTIVE, USING CLINICAL TRIAL OUTCOMES

Autor:	AG Hartzema, Sy Kwon
Jazyk:	angličtina
Předmět:	Clinical trial medicine.medical_specialty Cost–benefit analysis business.industry Health Policy Almotriptan Societal perspective Public Health Environmental and Occupational Health medicine Intensive care medicine business medicine.drug
Zdroj:	Value in Health. (3):270-271
ISSN:	1098-3015
DOI:	10.1016/S1098-3015(10)61171-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6012f5cf8c57275abd8e4bdec0a30d Zobrazit plný text záznamu